Status:
COMPLETED
The Burden of COVID-19 Survivorship
Lead Sponsor:
Mayo Clinic
Conditions:
Covid19
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
This research study is being done to find out what the longer-term physiological consequences of COVID-19 are, and to determine if exercise therapy can help improve lung function, heart function and o...
Detailed Description
The purpose of this research is to see if taking part in structured exercise training will improve the ability to exercise, the function of the lungs and the function of the heart, and reduce symptoms...
Eligibility Criteria
Inclusion
- Aged 21 to 75 years.
- History of RT-PCR proven SARS-CoV-2 infection.
- Deemed 'recovered' from SARS-CoV-2 infection.
- Not clinically obese (BMI ≥ 36) and/or suffer from musculoskeletal or other conditions that would limit exercise participation.
- No evidence of cardiac ischemia at rest or during exertion (via ECG).
- Able to provide written informed consent.
Exclusion
- Individuals less than 21 or more than 75 years old.
- Not able to take part in structured exercise training due to injury or other conditions that would put person at risk during exercise.
- Unable to provide written informed consent.
Key Trial Info
Start Date :
November 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04913129
Start Date
November 4 2021
End Date
December 31 2024
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224